Nephro Genetic Testing Market Research Report 2024 | Valuates Reports

Nephro Genetic Testing market was valued at US$ 353 million in 2023 and is anticipated to reach US$ 547.2 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.

Nephrogenetic disorder are hereditary and are passed from one generation to another. These are caused by any genetic alteration in the genes affecting the kidney functions and formation of renal cyst. Some of the common genetic renal disorders include Autosomal Dominant Polycystic Kidney Disease (ADPKD), Gitelman Syndrome, Nephronophthisis, etc. The nephro genetic testing market is majorly driven by advancements in DNA sequencing techniques and increasing research in the domain. These method provide an accurate course of treatment and specific investigations.

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1K10648/Global_Nephro_Genetic_Testing_Market_Research_Report_2022

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Nephro Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nephro Genetic Testing.

Purchase Regional Report: https://reports.valuates.com/request/regional/QYRE-Auto-1K10648/Global_Nephro_Genetic_Testing_Market_Research_Report_2022

By Type
• Next Generation Sequencing
• Multiplex Ligation-dependent Probe Amplification (MLPA

By Application
• Hospitals
• Specialty Clinics
• Diagnostics Laboratories
• Others

Key Players
Centogene, MedGenome, Blueprint Genetics, Invitae Corporation, Natera

View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-1K10648/global-nephro-genetic-testing

Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.